[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"supraspinatus-tendinitis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:supraspinatus-tendinitis":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,40,63,85],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100637825","hilt-vs-eswt-in-supraspinatus-tendinitis-100637825",false,"NCT07615920","HILT vs ESWT in Supraspinatus Tendinitis","Comparative Effectiveness of High-Intensity Laser Therapy Versus Extracorporeal Shock Wave Therapy in Patients With Supraspinatus Tendinitis","Inclusion Criteria:\n\n* Male and female participants aged between 18 and 60 years.\n* Clinically diagnosed supraspinatus tendinitis confirmed by ultrasound imaging.\n* Shoulder pain duration greater than 3 months.\n* Ability to understand and follow study instructions.\n* Willingness to participate and provide informed consent.\n\nExclusion Criteria:\n\n* Full-thickness rotator cuff tear.\n* Previous shoulder surgery.\n* Pregnancy.\n* Neurological disorders affecting the upper limb.\n* Corticosteroid injection within the previous 3 months.\n* Shoulder fracture or dislocation.\n* Systemic inflammatory diseases.\n* Participation in other physical therapy programs during the study period","ALL","18 Years","60 Years",{"count":20,"type":21},48,"ESTIMATED","INTERVENTIONAL",[24],"NA","This randomized controlled trial aims to compare the effectiveness of High-Intensity Laser Therapy (HILT) and Extracorporeal Shock Wave Therapy (ESWT) in patients with supraspinatus tendinitis.",[27],"Supraspinatus Tendinitis","NOT_YET_RECRUITING","2026-05-25",{"date":31,"type":32},"2026-05-29","ACTUAL",{"date":34,"type":21},"2026-08-01",{"date":36,"type":21},"2027-12-30",{"name":38,"class":39},"Kafrelsheikh University","OTHER",{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":16,"minAge":46,"maxAge":18,"enrollmentInfo":47,"targetDuration":4,"studyType":22,"phases":49,"briefSummary":50,"conditions":51,"keywords":4,"overallStatus":52,"whyStopped":4,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":62},"100629095","anatomical-evaluation-of-supraspinatus-through-ultrasonography-and-biomechanical-measurements-following-different-combinations-of-physical-therapies-in-patients-of-supraspinatus-tendinitis-100629095","NCT07470190","Anatomical Evaluation of Supraspinatus Through Ultrasonography and Biomechanical Measurements Following Different Combinations of Physical Therapies in Patients of Supraspinatus Tendinitis","Inclusion Criteria:\n\n* unilateral shoulder pain\n* both gender group\n* two positive tests of (Neer impingement test, Hawkins-Kendy test, Empty can test),\n* shoulder pain history up to 3 months\n* not receiving any physiotherapy last 3 months.\n* not receiving pain medications (NSAIDS) for last 15 days.\n\nExclusion Criteria:\n\n* referred shoulder pain\n* limited shoulder ROM less then 90 degree\n* previous shoulder surgery, intra articular injection or nerve block last 6 months.\n* patient with 180 mmHg blood pressure\u002Funcontrolled BP\n* upper limb fracture, uncontrolled diabetes, open wounds, fistula and vascular surgery.\n* pregnant woman or 6 month history of pregnancy","40 Years",{"count":48,"type":21},60,[24],"A randomized controlled trial will be conducted to get the expected outcomes. Patients of both gender groups with unilateral shoulder pain will be selected with age range 40-60 years from Sehat medical complex and randomly allocated into four groups (Group A, B, C and D) of two different trials (Trial I and Trial II). The sample size will be 120 patients for both trials. Musculoskeletal ultrasound, goniometry, pain pressure threshold, dynamometer and functional indices will be used to measure the tendon thickness, range of motion, pain, muscle strength and function level. The group A will get BFRT, Group B will get ESWT, group c will get the combination of both and group D will be the Control group (Routine physical therapy). In Trial II the group A will get BFRT, Group B will get Eccentric Training, Group C will get combination of both A \\& B and group D will be control group. data will be collected at baseline, 4th week, 8th week and 12 week of interventions. For data analysis SPSS version 25 will be used. Repeated measures ANOVA will be applied to compare the quantitative data within and between the groups. Post-Hoc test Tukey and Bonferroni correction will be used. The level of significance will be set at 5% (P\\\u003C0.05).",[27],"RECRUITING","2026-03-09",{"date":55,"type":32},"2026-03-13",{"date":57,"type":32},"2026-02-23",{"date":59,"type":21},"2026-08-30",{"name":61,"class":39},"Sehat Medical Complex",1,{"id":64,"slug":65,"hasResults":11,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":4,"eligibilityCriteria":68,"healthyVolunteers":11,"sex":16,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":4,"studyType":22,"phases":73,"briefSummary":74,"conditions":75,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":62},"100617291","effect-of-tecar-transfer-of-energy-capacitive-and-resistive-therapy-on-chronic-supraspinatus-tendinitis-100617291","NCT07316712","Effect of TECAR (Transfer of Energy Capacitive and Resistive) Therapy on Chronic Supraspinatus Tendinitis","Inclusion Criteria:\n\n* Supraspinatus Tendinitis grade II based on Neer's classification, confirmed by special tests, signs, and symptoms of grade I and II Supraspinatus Tendinitis for the past month, and taking non-steroidal anti-inflammatory drugs as suggested by the physician.\n* All patients will have a body mass index between 18.5 and 29.9 kg\u002Fm².\n\nExclusion Criteria:\n\n* Other grades of Supraspinatus Tendinitis.\n* Any past shoulder surgical interventions.\n* Instability of the shoulder joint due to other reasons, Acromioclavicular Joint Arthritis.\n* Non-cooperative subjects.\n* Diabetes\n* Pregnant or lactating women.\n* Serious neuromuscular or cardiovascular diseases.\n* Systemic illness and severe COVID-19 cases will be excluded from this study.\n* Pacemakers\n* Heat Sensitivity\n* Metal Implants","30 Years","55 Years",{"count":72,"type":21},46,[24],"This study aims to investigate the effect of TECAR therapy on pain, shoulder range of motion, functional disability, and handgrip strength in patients with grade II supraspinatus tendinitis.",[27],"2025-12-19",{"date":78,"type":32},"2026-01-05",{"date":80,"type":21},"2025-12-30",{"date":82,"type":21},"2026-02-28",{"name":84,"class":39},"Cairo University",{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":89,"acronym":4,"eligibilityCriteria":90,"healthyVolunteers":11,"sex":16,"minAge":69,"maxAge":18,"enrollmentInfo":91,"targetDuration":4,"studyType":22,"phases":93,"briefSummary":94,"conditions":95,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":96,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":62},"100617293","effect-of-ozonated-gel-phonophoresis-on-pain-and-functional-disability-in-patients-with-chronic-supraspinatus-tendinitis-100617293","NCT07316738","Effect of Ozonated Gel Phonophoresis on Pain and Functional Disability in Patients With Chronic Supraspinatus Tendinitis","Inclusion Criteria:\n\n* Patients from 30-60 years old from both genders.\n* The patients will be assigned to the study will be diagnosed with grade I or II supraspinatus tendinitis based on Neer's classification.\n* The patients suffered from supraspinatus tendinitis for more than 3 months and taking non-steroidal anti-inflammatory drugs suggested by orthopedist.\n* All patients have body mass index between 18.5 and 29.9 kg\u002Fm2.\n\nExclusion Criteria:\n\n* Grades III of supraspinatus tendinitis. (Bone spurs and tendon rapture)\n* Any past shoulder surgical interventions. (Rotator cuff repair, labrum tear and open reduction internal fixation)\n* Shoulder joint instability\n* Shoulder fracture.\n* Non-cooperative subjects.\n* Neuromuscular diseases (spinal muscular atrophy, whiplash injury)\n* Cardiovascular disease.\n* History of cancer.\n* Systemic diseases such as rheumatoid arthritis, Reiter's syndrome, or diabetes.\n* Severe medical and neurological or psychiatric disorders.\n* Pregnant and lactating women.",{"count":92,"type":21},40,[24],"This study will be conducted to investigate the effect of ozonated gel phonophoresis on pain intensity, shoulder joint range of motion, and functional disability in patients with chronic supraspinatus tendinitis grades I and II.",[27],{"date":78,"type":32},{"date":98,"type":21},"2025-12-25",{"date":100,"type":21},"2026-03-01",{"name":84,"class":39}]